CA2368489A1 - 50 proteines secretees d'origine humaine - Google Patents
50 proteines secretees d'origine humaine Download PDFInfo
- Publication number
- CA2368489A1 CA2368489A1 CA002368489A CA2368489A CA2368489A1 CA 2368489 A1 CA2368489 A1 CA 2368489A1 CA 002368489 A CA002368489 A CA 002368489A CA 2368489 A CA2368489 A CA 2368489A CA 2368489 A1 CA2368489 A1 CA 2368489A1
- Authority
- CA
- Canada
- Prior art keywords
- human
- seq
- sequence
- polypeptide
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
La présente invention a trait à de nouvelles protéines sécrétées d'origine humaine, et à des acides nucléiques isolés qui contiennent les régions codantes des gènes codant pour ces protéines. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des procédés de recombinaison utiles pour produire les protéines sécrétées d'origine humaine. L'invention concerne en outre des méthodes diagnostiques et thérapeutiques utiles pour diagnostiquer et traiter des maladies, des affections et/ou des états pathologiques associés à ces nouvelles protéines sécrétées d'origine humaine.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12651199P | 1999-03-26 | 1999-03-26 | |
US60/126,511 | 1999-03-26 | ||
US17241399P | 1999-12-17 | 1999-12-17 | |
US60/172,413 | 1999-12-17 | ||
PCT/US2000/007535 WO2000058356A1 (fr) | 1999-03-26 | 2000-03-22 | 50 proteines secretees d'origine humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2368489A1 true CA2368489A1 (fr) | 2000-10-05 |
Family
ID=26824746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002368489A Abandoned CA2368489A1 (fr) | 1999-03-26 | 2000-03-22 | 50 proteines secretees d'origine humaine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1171458A4 (fr) |
JP (1) | JP2003501008A (fr) |
AU (1) | AU3632700A (fr) |
CA (1) | CA2368489A1 (fr) |
WO (1) | WO2000058356A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6908747B2 (en) | 2001-03-29 | 2005-06-21 | Applera Corporation | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
WO2003048204A1 (fr) * | 2001-12-06 | 2003-06-12 | Takeda Chemical Industries, Ltd. | Gene associe a la maladie d'alzheimer, sa proteine et son utilisation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5654139A (en) * | 1994-09-21 | 1997-08-05 | The United States Of America As Represented By The Department Of Health And Human Services | Allelic variation of the serotonin 5HT2c receptor |
WO1999047540A1 (fr) * | 1998-03-19 | 1999-09-23 | Human Genome Sciences, Inc. | 95 proteines humaines secretees |
CA2291260A1 (fr) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 proteines secretees par l'etre humain |
-
2000
- 2000-03-22 JP JP2000608648A patent/JP2003501008A/ja not_active Withdrawn
- 2000-03-22 AU AU36327/00A patent/AU3632700A/en not_active Abandoned
- 2000-03-22 CA CA002368489A patent/CA2368489A1/fr not_active Abandoned
- 2000-03-22 EP EP00915023A patent/EP1171458A4/fr not_active Withdrawn
- 2000-03-22 WO PCT/US2000/007535 patent/WO2000058356A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1171458A4 (fr) | 2003-04-02 |
EP1171458A1 (fr) | 2002-01-16 |
JP2003501008A (ja) | 2003-01-14 |
AU3632700A (en) | 2000-10-16 |
WO2000058356A1 (fr) | 2000-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2368068A1 (fr) | 27 proteines humaines secretees | |
CA2382185A1 (fr) | 48 proteines secretees humaines | |
CA2368927A1 (fr) | Quarante-cinq proteines humaines secretees | |
CA2370489A1 (fr) | 49 proteines humaines secretees | |
CA2364209A1 (fr) | 49 proteines secretees humaines | |
CA2387696A1 (fr) | 48 proteines humaines secretees | |
CA2365223A1 (fr) | Proteines humaines secretees (46) | |
CA2368281A1 (fr) | 50 proteines humaines secretees | |
CA2368467A1 (fr) | 50 proteines humaines secretees | |
CA2391364A1 (fr) | 47 proteines humaines secretees | |
CA2364635A1 (fr) | 47 proteines humaines secretees | |
CA2368302A1 (fr) | 49 proteines secretees par un etre humain | |
CA2365522A1 (fr) | 48 proteines secretees humaines | |
CA2370441A1 (fr) | 50 proteines humaines secretees | |
CA2391361A1 (fr) | 47 proteines secretees humaines | |
CA2390946A1 (fr) | 49 proteines secretees humaines | |
CA2365247A1 (fr) | Proteines humaines secretees (49) | |
CA2368442A1 (fr) | 48 proteines humaines secretees | |
CA2364650A1 (fr) | Proteines humaines secretees (50) | |
CA2368374A1 (fr) | 47 proteines humaines secretees | |
CA2368719A1 (fr) | Cinquante proteines humaines secretees | |
CA2368916A1 (fr) | 49 proteines humaines secretees | |
CA2368700A1 (fr) | Quarante-neuf proteines humaines secretees | |
CA2367620A1 (fr) | Proteines humaines secretees (47) | |
CA2368210A1 (fr) | Cinquante proteines humaines secretees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |